LumiraGHK-Cu
Ordered GHK-Cu from Lumira? Mail in a sample (US only) and let us test it.
Test my supplyLumira GHK-Cu has a recent severe outlier: after a long run of 99.7-99.9% purity passes, the Oct. 30 sample showed 50.6% purity, -47% fill, no batch ID, and no identity result. The key question is whether it is isolated or a trend.
Corporate and domain records trace Lumira through Peptaura, dead direct storefronts and a new Welon/ABT layer with unresolved ownership. The report maps the registry mismatch, payment rails and promoter-code network behind the catalog.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Lumira rows.
Cancel anytime
Ordered GHK-Cu from Lumira? Mail in a sample (US only) and let us test it.
Test my supplyAbout Lumira test results from Finnrick
Lumira is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 115 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Lumira peptides in this dataset are BPC-157 (8 tests), CJC-1295 (2 tests) and GHK-Cu (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 115 recent tests. It also includes 2 corrections related to this vendor.
Ordered GHK-Cu from Lumira? Mail in a sample (US only) and let us test it.
Test my supply